• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

加拿大西部人和动物血清中产气荚膜梭菌肠毒素抗体的调查

A survey of Clostridium perfringens enterotoxin antibody in human and animal sera in western Canada.

作者信息

Niilo L, Bainborough A R

出版信息

Can J Microbiol. 1980 Sep;26(9):1162-4. doi: 10.1139/m80-192.

DOI:10.1139/m80-192
PMID:6257364
Abstract

Sera from human, cattle, sheep, swine, and horse populations in western Canada were tested for the presence of Clostridium perfringens enterotoxin antibody by the passive hemagglutination (PHA) test, supplemented by an immunodiffusion test and by counterimmunoelectrophoresis. A total of 224 human, 345 cattle, 165 sheep, 620 swine, and 768 horse serum samples were examined. Low-titer reactions in the PHA test were detected in human, cattle, horse, and swine sera, in that order, with no titers demonstrated in sheep. The titers in human sera ranged up to 1:128 and three of these samples were also positive in the other two serological tests. The significance of this antibody is not clear, but it is suggested that the low prevalence of the antibody may reflect a low prevalence of enterotoxigenic C. perfringens strains in western Canada. Such serological surveys may be applicable to epidemiological studies involving enterotoxigenic C perfringens.

摘要

采用被动血凝试验(PHA),并辅以免疫扩散试验和对流免疫电泳,检测了加拿大西部人群、牛群、羊群、猪群和马群血清中是否存在产气荚膜梭菌肠毒素抗体。共检测了224份人血清、345份牛血清、165份羊血清、620份猪血清和768份马血清样本。在PHA试验中,人、牛、马和猪血清依次检测到低滴度反应,而羊血清未显示滴度。人血清中的滴度最高可达1:128,其中三份样本在其他两项血清学试验中也呈阳性。这种抗体的意义尚不清楚,但有人认为,抗体的低流行率可能反映了加拿大西部产肠毒素产气荚膜梭菌菌株的低流行率。此类血清学调查可能适用于涉及产肠毒素产气荚膜梭菌的流行病学研究。

相似文献

1
A survey of Clostridium perfringens enterotoxin antibody in human and animal sera in western Canada.加拿大西部人和动物血清中产气荚膜梭菌肠毒素抗体的调查
Can J Microbiol. 1980 Sep;26(9):1162-4. doi: 10.1139/m80-192.
2
An enzyme-linked immunosorbent assay for the detection of Clostridium perfringens enterotoxin antibody.一种用于检测产气荚膜梭菌肠毒素抗体的酶联免疫吸附测定法。
Can J Comp Med. 1984 Jan;48(1):111-2.
3
Detection of Clostridium perfringens enterotoxin in human fecal samples and anti-enterotoxin in sera.检测人粪便样本中的产气荚膜梭菌肠毒素及血清中的抗肠毒素。
J Clin Microbiol. 1978 Apr;7(4):337-40. doi: 10.1128/jcm.7.4.337-340.1978.
4
Enterotoxigenic Clostridium perfringens type A isolated from intestinal contents of cattle, sheep and chickens.从牛、羊和鸡的肠道内容物中分离出的产肠毒素A型产气荚膜梭菌。
Can J Comp Med. 1978 Jul;42(3):357-63.
5
Identification of enterotoxigenic Clostridium perfringens type A in mixed cultures.混合培养物中A型产肠毒素性产气荚膜梭菌的鉴定
Can J Comp Med. 1979 Jan;43(1):98-101.
6
Antibody against Clostridium perfringens type A enterotoxin in human sera.人血清中抗A型产气荚膜梭菌肠毒素抗体。
Infect Immun. 1974 Feb;9(2):470-1. doi: 10.1128/iai.9.2.470-471.1974.
7
Serum antibody to Escherichia coli heat-labile enterotoxin in cattle and swine.
Am J Vet Res. 1976 Aug;37(8):905-6.
8
Experimental diarrhea in cynomolgus monkeys by oral administration with Clostridium perfringens type A viable cells or enterotoxin.通过口服A型产气荚膜梭菌活细胞或肠毒素诱导食蟹猴实验性腹泻。
Jpn J Med Sci Biol. 1975 Jun;28(3):165-77. doi: 10.7883/yoken1952.28.165.
9
Vaccination of cattle and sheep with a combined Clostridium perfringens types C and D toxoid.用产气荚膜梭菌C型和D型类毒素联合疫苗对牛羊进行接种。
Am J Vet Res. 1977 Oct;38(10):1515-7.
10
Porcine Clostridium perfringens type A spores, enterotoxin and antibody to enterotoxin.猪A型产气荚膜梭菌孢子、肠毒素及抗肠毒素抗体。
Vet Rec. 1989 Jun 10;124(23):606-10. doi: 10.1136/vr.124.23.606.

引用本文的文献

1
An enzyme-linked immunosorbent assay for the detection of Clostridium perfringens enterotoxin antibody.一种用于检测产气荚膜梭菌肠毒素抗体的酶联免疫吸附测定法。
Can J Comp Med. 1984 Jan;48(1):111-2.
2
Clinical and antibody responses to Clostridium perfringens type A enterotoxin in experimental sheep and calves.实验性绵羊和犊牛对A型产气荚膜梭菌肠毒素的临床及抗体反应
Can J Comp Med. 1985 Apr;49(2):145-8.